1 Study Coverage
1.1 Telomerase Reverse Transcriptase Product Introduction
1.2 Market Segments
1.3 Key Telomerase Reverse Transcriptase Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Telomerase Reverse Transcriptase Market Size Growth Rate by Type
1.4.2 ASTVAC-1
1.4.3 ASTVAC-2
1.4.4 ETS-2300
1.4.5 Others
1.5 Market by Application
1.5.1 Global Telomerase Reverse Transcriptase Market Size Growth Rate by Application
1.5.2 Lung Cancer
1.5.3 Ovarian Cancer
1.5.4 Breast Cancer
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Telomerase Reverse Transcriptase Market Size, Estimates and Forecasts
2.1.1 Global Telomerase Reverse Transcriptase Revenue 2015-2026
2.1.2 Global Telomerase Reverse Transcriptase Sales 2015-2026
2.2 Global Telomerase Reverse Transcriptase, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Telomerase Reverse Transcriptase Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Telomerase Reverse Transcriptase Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Telomerase Reverse Transcriptase Competitor Landscape by Players
3.1 Telomerase Reverse Transcriptase Sales by Manufacturers
3.1.1 Telomerase Reverse Transcriptase Sales by Manufacturers (2015-2020)
3.1.2 Telomerase Reverse Transcriptase Sales Market Share by Manufacturers (2015-2020)
3.2 Telomerase Reverse Transcriptase Revenue by Manufacturers
3.2.1 Telomerase Reverse Transcriptase Revenue by Manufacturers (2015-2020)
3.2.2 Telomerase Reverse Transcriptase Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Telomerase Reverse Transcriptase Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Telomerase Reverse Transcriptase Revenue in 2019
3.2.5 Global Telomerase Reverse Transcriptase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Telomerase Reverse Transcriptase Price by Manufacturers
3.4 Telomerase Reverse Transcriptase Manufacturing Base Distribution, Product Types
3.4.1 Telomerase Reverse Transcriptase Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Telomerase Reverse Transcriptase Product Type
3.4.3 Date of International Manufacturers Enter into Telomerase Reverse Transcriptase Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Telomerase Reverse Transcriptase Market Size by Type (2015-2020)
4.1.1 Global Telomerase Reverse Transcriptase Sales by Type (2015-2020)
4.1.2 Global Telomerase Reverse Transcriptase Revenue by Type (2015-2020)
4.1.3 Telomerase Reverse Transcriptase Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Telomerase Reverse Transcriptase Market Size Forecast by Type (2021-2026)
4.2.1 Global Telomerase Reverse Transcriptase Sales Forecast by Type (2021-2026)
4.2.2 Global Telomerase Reverse Transcriptase Revenue Forecast by Type (2021-2026)
4.2.3 Telomerase Reverse Transcriptase Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Telomerase Reverse Transcriptase Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Telomerase Reverse Transcriptase Market Size by Application (2015-2020)
5.1.1 Global Telomerase Reverse Transcriptase Sales by Application (2015-2020)
5.1.2 Global Telomerase Reverse Transcriptase Revenue by Application (2015-2020)
5.1.3 Telomerase Reverse Transcriptase Price by Application (2015-2020)
5.2 Telomerase Reverse Transcriptase Market Size Forecast by Application (2021-2026)
5.2.1 Global Telomerase Reverse Transcriptase Sales Forecast by Application (2021-2026)
5.2.2 Global Telomerase Reverse Transcriptase Revenue Forecast by Application (2021-2026)
5.2.3 Global Telomerase Reverse Transcriptase Price Forecast by Application (2021-2026)
6 North America
6.1 North America Telomerase Reverse Transcriptase by Country
6.1.1 North America Telomerase Reverse Transcriptase Sales by Country
6.1.2 North America Telomerase Reverse Transcriptase Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Telomerase Reverse Transcriptase Market Facts & Figures by Type
6.3 North America Telomerase Reverse Transcriptase Market Facts & Figures by Application
7 Europe
7.1 Europe Telomerase Reverse Transcriptase by Country
7.1.1 Europe Telomerase Reverse Transcriptase Sales by Country
7.1.2 Europe Telomerase Reverse Transcriptase Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Telomerase Reverse Transcriptase Market Facts & Figures by Type
7.3 Europe Telomerase Reverse Transcriptase Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Telomerase Reverse Transcriptase by Region
8.1.1 Asia Pacific Telomerase Reverse Transcriptase Sales by Region
8.1.2 Asia Pacific Telomerase Reverse Transcriptase Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Telomerase Reverse Transcriptase Market Facts & Figures by Type
8.3 Asia Pacific Telomerase Reverse Transcriptase Market Facts & Figures by Application
9 Latin America
9.1 Latin America Telomerase Reverse Transcriptase by Country
9.1.1 Latin America Telomerase Reverse Transcriptase Sales by Country
9.1.2 Latin America Telomerase Reverse Transcriptase Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Telomerase Reverse Transcriptase Market Facts & Figures by Type
9.3 Central & South America Telomerase Reverse Transcriptase Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Telomerase Reverse Transcriptase by Country
10.1.1 Middle East and Africa Telomerase Reverse Transcriptase Sales by Country
10.1.2 Middle East and Africa Telomerase Reverse Transcriptase Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Telomerase Reverse Transcriptase Market Facts & Figures by Type
10.3 Middle East and Africa Telomerase Reverse Transcriptase Market Facts & Figures by Application
11 Company Profiles
11.1 Argos Therapeutics Inc
11.1.1 Argos Therapeutics Inc Corporation Information
11.1.2 Argos Therapeutics Inc Description and Business Overview
11.1.3 Argos Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Argos Therapeutics Inc Telomerase Reverse Transcriptase Products Offered
11.1.5 Argos Therapeutics Inc Related Developments
11.2 Asterias Biotherapeutics Inc
11.2.1 Asterias Biotherapeutics Inc Corporation Information
11.2.2 Asterias Biotherapeutics Inc Description and Business Overview
11.2.3 Asterias Biotherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Asterias Biotherapeutics Inc Telomerase Reverse Transcriptase Products Offered
11.2.5 Asterias Biotherapeutics Inc Related Developments
11.3 e-Therapeutics Plc
11.3.1 e-Therapeutics Plc Corporation Information
11.3.2 e-Therapeutics Plc Description and Business Overview
11.3.3 e-Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 e-Therapeutics Plc Telomerase Reverse Transcriptase Products Offered
11.3.5 e-Therapeutics Plc Related Developments
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Corporation Information
11.4.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.4.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Ltd Telomerase Reverse Transcriptase Products Offered
11.4.5 F. Hoffmann-La Roche Ltd Related Developments
11.5 Inovio Pharmaceuticals Inc
11.5.1 Inovio Pharmaceuticals Inc Corporation Information
11.5.2 Inovio Pharmaceuticals Inc Description and Business Overview
11.5.3 Inovio Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Inovio Pharmaceuticals Inc Telomerase Reverse Transcriptase Products Offered
11.5.5 Inovio Pharmaceuticals Inc Related Developments
11.6 Invectys SA
11.6.1 Invectys SA Corporation Information
11.6.2 Invectys SA Description and Business Overview
11.6.3 Invectys SA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Invectys SA Telomerase Reverse Transcriptase Products Offered
11.6.5 Invectys SA Related Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Description and Business Overview
11.7.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Telomerase Reverse Transcriptase Products Offered
11.7.5 Johnson & Johnson Related Developments
11.8 Komipharm International Co Ltd
11.8.1 Komipharm International Co Ltd Corporation Information
11.8.2 Komipharm International Co Ltd Description and Business Overview
11.8.3 Komipharm International Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Komipharm International Co Ltd Telomerase Reverse Transcriptase Products Offered
11.8.5 Komipharm International Co Ltd Related Developments
11.9 Mediolanum farmaceutici SpA
11.9.1 Mediolanum farmaceutici SpA Corporation Information
11.9.2 Mediolanum farmaceutici SpA Description and Business Overview
11.9.3 Mediolanum farmaceutici SpA Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Mediolanum farmaceutici SpA Telomerase Reverse Transcriptase Products Offered
11.9.5 Mediolanum farmaceutici SpA Related Developments
11.10 Telocyte LLC
11.10.1 Telocyte LLC Corporation Information
11.10.2 Telocyte LLC Description and Business Overview
11.10.3 Telocyte LLC Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Telocyte LLC Telomerase Reverse Transcriptase Products Offered
11.10.5 Telocyte LLC Related Developments
11.1 Argos Therapeutics Inc
11.1.1 Argos Therapeutics Inc Corporation Information
11.1.2 Argos Therapeutics Inc Description and Business Overview
11.1.3 Argos Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Argos Therapeutics Inc Telomerase Reverse Transcriptase Products Offered
11.1.5 Argos Therapeutics Inc Related Developments
11.12 Ultimovacs AS
11.12.1 Ultimovacs AS Corporation Information
11.12.2 Ultimovacs AS Description and Business Overview
11.12.3 Ultimovacs AS Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Ultimovacs AS Products Offered
11.12.5 Ultimovacs AS Related Developments
11.13 Vaxon Biotech
11.13.1 Vaxon Biotech Corporation Information
11.13.2 Vaxon Biotech Description and Business Overview
11.13.3 Vaxon Biotech Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Vaxon Biotech Products Offered
11.13.5 Vaxon Biotech Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Telomerase Reverse Transcriptase Market Estimates and Projections by Region
12.1.1 Global Telomerase Reverse Transcriptase Sales Forecast by Regions 2021-2026
12.1.2 Global Telomerase Reverse Transcriptase Revenue Forecast by Regions 2021-2026
12.2 North America Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.2.1 North America: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.2.2 North America: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.2.3 North America: Telomerase Reverse Transcriptase Market Size Forecast by Country (2021-2026)
12.3 Europe Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.3.1 Europe: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.3.2 Europe: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.3.3 Europe: Telomerase Reverse Transcriptase Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Telomerase Reverse Transcriptase Market Size Forecast by Region (2021-2026)
12.5 Latin America Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.5.1 Latin America: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.5.2 Latin America: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.5.3 Latin America: Telomerase Reverse Transcriptase Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Telomerase Reverse Transcriptase Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Telomerase Reverse Transcriptase Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Telomerase Reverse Transcriptase Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Telomerase Reverse Transcriptase Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Telomerase Reverse Transcriptase Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Telomerase Reverse Transcriptase Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Argos Therapeutics Inc、Asterias Biotherapeutics Inc、e-Therapeutics Plc、F. Hoffmann-La Roche Ltd、Inovio Pharmaceuticals Inc、Invectys SA、Johnson & Johnson、Komipharm International Co Ltd、Mediolanum farmaceutici SpA、Telocyte LLC、TILT Biotherapeutics Ltd、Ultimovacs AS、Vaxon Biotech
【免責事項】
https://www.globalresearch.jp/disclaimer